Nathaniel Hathaway
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2020First federal award
$601KFederal grants as PI2 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
2 awards · $601K
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Sep 16, 2021 | NIH | STTR Phase I Site-specific epigenetic activation of TP53 to improve cancer therapy | $350K | Epigenos Bioscience, Inc. with UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL |
| Apr 1, 2020 | NIH | STTR Phase I Chemically controlling chromatin to treat Friedriech's Ataxia | $251K | Epigenos Bioscience, Inc. with UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL |
Peer ranks
Federal funding#2,187
Awards as PI#1,252
Patents#273
Companies
- Epigenos Bioscience, Inc.Linked by awards · Biotech
Research institutions
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.